ATE404215T1 - Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion - Google Patents

Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion

Info

Publication number
ATE404215T1
ATE404215T1 AT02742656T AT02742656T ATE404215T1 AT E404215 T1 ATE404215 T1 AT E404215T1 AT 02742656 T AT02742656 T AT 02742656T AT 02742656 T AT02742656 T AT 02742656T AT E404215 T1 ATE404215 T1 AT E404215T1
Authority
AT
Austria
Prior art keywords
group
hiv infection
pharmaceutical composition
treating hiv
amino
Prior art date
Application number
AT02742656T
Other languages
English (en)
Inventor
Genfa Zhou
Wangni Tian
Original Assignee
Tianjin Fusogen Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Fusogen Biotech Co Ltd filed Critical Tianjin Fusogen Biotech Co Ltd
Application granted granted Critical
Publication of ATE404215T1 publication Critical patent/ATE404215T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT02742656T 2001-08-29 2002-06-06 Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion ATE404215T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN01130985A CN1100564C (zh) 2001-08-29 2001-08-29 用于治疗hiv感染的药物、其组合物及其用途

Publications (1)

Publication Number Publication Date
ATE404215T1 true ATE404215T1 (de) 2008-08-15

Family

ID=4670295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742656T ATE404215T1 (de) 2001-08-29 2002-06-06 Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion

Country Status (9)

Country Link
US (2) US6962900B2 (de)
EP (1) EP1421946B1 (de)
JP (1) JP2004538334A (de)
CN (1) CN1100564C (de)
AT (1) ATE404215T1 (de)
DE (1) DE60228269D1 (de)
DK (1) DK1421946T3 (de)
RU (1) RU2290197C2 (de)
WO (1) WO2003018045A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
AU2004313242A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
TWI341844B (en) 2006-02-02 2011-05-11 Trimeris Inc Hiv fusion inhibitor peptides with improved biological properties
WO2007130523A2 (en) * 2006-05-05 2007-11-15 George Mason Intellectual Properties, Inc. Compositions and methods for detecting and treating hiv infection
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
CA2682848A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics
CN101874038A (zh) * 2007-09-25 2010-10-27 特里梅里斯公司 治疗性抗-hiv肽的合成方法
US20100021427A1 (en) * 2008-05-29 2010-01-28 Tianjin Fusogen Pharmaceuticals, Inc. Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV
EP2603241A2 (de) 2010-08-11 2013-06-19 Jv Bio Srl Multimere virenfusionshemmer und ihre verwendung
CN102180951B (zh) * 2011-05-03 2012-09-26 中国医学科学院病原生物学研究所 胆固醇修饰的抗hiv多肽药物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI922044A0 (fi) * 1990-09-11 1992-05-06 Seikagaku Kogyo Co Ltd Ny polypeptid och daerav framstaelld hiv-medicin.
HUT61036A (en) * 1991-05-02 1992-11-30 Seikagaku Kogyo Co Ltd Process for producing new polypeptides capable of linking to lipopolysaccharides and pharmaceutical compositions comprising same as active ingredients
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
KR100358209B1 (ko) * 1992-07-20 2003-01-24 듀크 유니버시티 Hiv복제를저해하는조성물
DE69426725T2 (de) * 1993-09-11 2001-09-06 Polimun Scientific Immunbiologische Forschungsgesellschaft Mbh, Wien Peptide, die neutralisierende antikörper gegen genetisch divergierende hiv-1 stämme, induzieren
IL110929A0 (en) * 1993-09-13 1994-11-28 Armel Sa Multiple branch peptide constructions and pharmaceutical compositions containing them
JPH08504837A (ja) * 1993-10-14 1996-05-28 生化学工業株式会社 新規ポリペプチドおよびこれから調製される抗ｈｉｖ剤
RU2137768C1 (ru) * 1993-12-15 1999-09-20 Мерк энд Ко, Инк. Ингибиторы hiv протеазы
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
WO1999062945A2 (en) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptide antigens for detection of hiv, hcv and other microbial infections
EP1100818B1 (de) * 1998-07-30 2013-01-02 Whitehead Institute For Biomedical Research Inhibitoren der membranfusion von hiv
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途

Also Published As

Publication number Publication date
US20040248789A1 (en) 2004-12-09
RU2004108858A (ru) 2005-05-10
WO2003018045A1 (en) 2003-03-06
CN1334122A (zh) 2002-02-06
US20060100139A1 (en) 2006-05-11
US7335727B2 (en) 2008-02-26
DK1421946T3 (da) 2008-12-01
CN1100564C (zh) 2003-02-05
DE60228269D1 (de) 2008-09-25
US6962900B2 (en) 2005-11-08
EP1421946A4 (de) 2005-08-31
RU2290197C2 (ru) 2006-12-27
EP1421946B1 (de) 2008-08-13
EP1421946A1 (de) 2004-05-26
JP2004538334A (ja) 2004-12-24
HK1067531A1 (en) 2005-04-15

Similar Documents

Publication Publication Date Title
AU3413100A (en) Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase
BR0115447A (pt) Inibidores de tripeptìdeo de hepatite c
WO2002065986A3 (en) Transporters comprising spaced arginine moieties
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
GB2431404A (en) Peptide
AU5252893A (en) Inhibitors of HIV protease useful for the treatment of AIDS
ATE404215T1 (de) Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
DE60221508D1 (de) Aminosäurederivate als hiv-protease-inhibitoren
ATE312079T1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
WO2004085682A3 (de) Caspase inhibitoren, insbesondere von caspase-3, zur behandlung von influenza
DE60136381D1 (de) Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DE69909747D1 (de) Pharmazeutische zusammensetzung, enthaltend peg-asparaginase, für die behandlung von hiv infektionen
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
GB9930768D0 (en) Composition
AU3705400A (en) Acetylated and related analogues of chicoric acid as hiv integrase inhibitors
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
HK1041444A1 (zh) 用於治療hiv感染的包含peg-天冬酰胺酶的藥物組合物
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor
DE602004030536D1 (de) Pyrrolidinohydrochinazoline
WO1998023574A8 (en) Asiatic acid derivatives and medicines for treating wounds, which contains the same
WO2002002087A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties